Article
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.
The Journal of infectious diseases - 1 Jul 2005
Eshleman Susan H, Hoover Donald R, Chen Shu, Hudelson Sarah E, Guay Laura A, Mwatha Anthony, Fiscus Susan A, Mmiro Francis, Musoke Philippa, Jackson J Brooks, Kumwenda Newton, Taha Taha
Abstract excerpt
OBJECTIVE: In the Human Immunodeficiency Virus (HIV) Network for Prevention Trials (HIVNET) 012 trial in Uganda, 6-8 weeks after single-dose nevirapine (SD-NVP), NVP resistance mutations were detected at a higher rate in women with HIV-1 subtype D than in women with subtype A. Here, we evaluate the rate of NVP resistance mutations in women with subtype C. METHODS: NVP resistance mutations were detected using the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
